Literature DB >> 26070106

HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.

Dennis L Buckley, Kanak Raina, Nicole Darricarrere, John Hines, Jeffrey L Gustafson, Ian E Smith1, Afjal H Miah1, John D Harling1, Craig M Crews.   

Abstract

Small molecule-induced protein degradation is an attractive strategy for the development of chemical probes. One method for inducing targeted protein degradation involves the use of PROTACs, heterobifunctional molecules that can recruit specific E3 ligases to a desired protein of interest. PROTACs have been successfully used to degrade numerous proteins in cells, but the peptidic E3 ligase ligands used in previous PROTACs have hindered their development into more mature chemical probes or therapeutics. We report the design of a novel class of PROTACs that incorporate small molecule VHL ligands to successfully degrade HaloTag7 fusion proteins. These HaloPROTACs will inspire the development of future PROTACs with more drug-like properties. Additionally, these HaloPROTACs are useful chemical genetic tools, due to their ability to chemically knock down widely used HaloTag7 fusion proteins in a general fashion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26070106      PMCID: PMC4629848          DOI: 10.1021/acschembio.5b00442

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  38 in total

1.  Impact of linker length on the activity of PROTACs.

Authors:  Kedra Cyrus; Marie Wehenkel; Eun-Young Choi; Hyeong-Jun Han; Hyosung Lee; Hollie Swanson; Kyung-Bo Kim
Journal:  Mol Biosyst       Date:  2010-10-04

2.  Precise control of protein concentration in living cells.

Authors:  Hubert D Lau; Junko Yaegashi; Balyn W Zaro; Matthew R Pratt
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

3.  HaloTag7: a genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification.

Authors:  Rachel Friedman Ohana; Lance P Encell; Kate Zhao; Dan Simpson; Michael R Slater; Marjeta Urh; Keith V Wood
Journal:  Protein Expr Purif       Date:  2009-05-21       Impact factor: 1.650

4.  HaloTag: a novel protein labeling technology for cell imaging and protein analysis.

Authors:  Georgyi V Los; Lance P Encell; Mark G McDougall; Danette D Hartzell; Natasha Karassina; Chad Zimprich; Monika G Wood; Randy Learish; Rachel Friedman Ohana; Marjeta Urh; Dan Simpson; Jacqui Mendez; Kris Zimmerman; Paul Otto; Gediminas Vidugiris; Ji Zhu; Aldis Darzins; Dieter H Klaubert; Robert F Bulleit; Keith V Wood
Journal:  ACS Chem Biol       Date:  2008-06-20       Impact factor: 5.100

5.  Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Authors:  A Rodriguez-Gonzalez; K Cyrus; M Salcius; K Kim; C M Crews; R J Deshaies; K M Sakamoto
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

6.  Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.

Authors:  Yukihiro Itoh; Minoru Ishikawa; Mikihiko Naito; Yuichi Hashimoto
Journal:  J Am Chem Soc       Date:  2010-04-28       Impact factor: 15.419

7.  Two-headed PROTAC: an effective new tool for targeted protein degradation.

Authors:  Kedra Cyrus; Marie Wehenkel; Eun-Young Choi; Hollie Swanson; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2010-07-26       Impact factor: 3.164

Review 8.  Protacs for treatment of cancer.

Authors:  Kathleen M Sakamoto
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

9.  Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics.

Authors:  Ashley R Schneekloth; Mathieu Pucheault; Hyun Seop Tae; Craig M Crews
Journal:  Bioorg Med Chem Lett       Date:  2008-07-31       Impact factor: 2.823

10.  Targeted degradation of the aryl hydrocarbon receptor by the PROTAC approach: a useful chemical genetic tool.

Authors:  Hyosung Lee; Dinesh Puppala; Eun-Young Choi; Hollie Swanson; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2007-11-23       Impact factor: 3.164

View more
  101 in total

1.  Protein degradation: Prime time for PROTACs.

Authors:  Raymond J Deshaies
Journal:  Nat Chem Biol       Date:  2015-09       Impact factor: 15.040

Review 2.  Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective.

Authors:  Xinrui Yang; He Yin; Richard D Kim; Jason B Fleming; Hao Xie
Journal:  Target Oncol       Date:  2020-12-28       Impact factor: 4.493

3.  PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.

Authors:  Kanak Raina; Jing Lu; Yimin Qian; Martha Altieri; Deborah Gordon; Ann Marie K Rossi; Jing Wang; Xin Chen; Hanqing Dong; Kam Siu; James D Winkler; Andrew P Crew; Craig M Crews; Kevin G Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

4.  Protein degradation: DCAFinating splicing.

Authors:  Georg E Winter
Journal:  Nat Chem Biol       Date:  2017-04-24       Impact factor: 15.040

5.  The trimeric coiled-coil HSBP1 protein promotes WASH complex assembly at centrosomes.

Authors:  Sai P Visweshwaran; Peter A Thomason; Raphael Guerois; Sophie Vacher; Evgeny V Denisov; Lubov A Tashireva; Maria E Lomakina; Christine Lazennec-Schurdevin; Goran Lakisic; Sergio Lilla; Nicolas Molinie; Veronique Henriot; Yves Mechulam; Antonina Y Alexandrova; Nadezhda V Cherdyntseva; Ivan Bièche; Emmanuelle Schmitt; Robert H Insall; Alexis Gautreau
Journal:  EMBO J       Date:  2018-05-29       Impact factor: 11.598

Review 6.  Targeted Protein Degradation by Small Molecules.

Authors:  Daniel P Bondeson; Craig M Crews
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-10-12       Impact factor: 13.820

7.  Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy.

Authors:  Rati Verma
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study.

Authors:  George M Burslem; Blake E Smith; Ashton C Lai; Saul Jaime-Figueroa; Daniel C McQuaid; Daniel P Bondeson; Momar Toure; Hanqing Dong; Yimin Qian; Jing Wang; Andrew P Crew; John Hines; Craig M Crews
Journal:  Cell Chem Biol       Date:  2017-11-09       Impact factor: 8.116

9.  An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells.

Authors:  Ekaterina V Vinogradova; Xiaoyu Zhang; David Remillard; Daniel C Lazar; Radu M Suciu; Yujia Wang; Giulia Bianco; Yu Yamashita; Vincent M Crowley; Michael A Schafroth; Minoru Yokoyama; David B Konrad; Kenneth M Lum; Gabriel M Simon; Esther K Kemper; Michael R Lazear; Sifei Yin; Megan M Blewett; Melissa M Dix; Nhan Nguyen; Maxim N Shokhirev; Emily N Chin; Luke L Lairson; Bruno Melillo; Stuart L Schreiber; Stefano Forli; John R Teijaro; Benjamin F Cravatt
Journal:  Cell       Date:  2020-07-29       Impact factor: 41.582

10.  Selective Targeting of Cells via Bispecific Molecules That Exploit Coexpression of Two Intracellular Proteins.

Authors:  Bryan M Dunyak; Robert L Nakamura; Alan D Frankel; Jason E Gestwicki
Journal:  ACS Chem Biol       Date:  2015-09-02       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.